Abstract

Idiopathic thrombocytopenic purpura (ITP) in children is a heterogeneous disease from the point of view of its natural course and pattern of treatment response. Even in uncomplicated ITP, there is a large variation in disease presentation and prognosis. Although in children it is usually a self limited disorder [1], chronicity (evolution longer than 6 months) and life-threatening bleeds are the main challenges of patients with ITP, justifying preoccupations for their prediction and prevention [2].

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call